市場調査レポート
商品コード
1177361

抗生物質の世界市場 2023-2027

Global Antibiotics Market 2023-2027

出版日: | 発行: TechNavio | ページ情報: 英文 163 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.28円
抗生物質の世界市場 2023-2027
出版日: 2022年12月06日
発行: TechNavio
ページ情報: 英文 163 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは抗生物質の市場規模は、2022年から2027年の間に170億6,666万米ドルの増加が見込まれ、予測期間中にCAGR6.07%で成長すると予測しています。

当レポートでは、抗生物質市場の全体的な分析、市場規模と予測、動向、成長促進要因・課題、さらに約25のベンダーを網羅したベンダー分析などを提供しています。

現在の世界の市場動向と促進要因、市場環境全体に関する最新の分析を提供しています。市場は、感染症の蔓延、様々な疾患とその治療に対する意識の高まり、特別な規制の指定によって牽引されています。

本調査では、戦略的提携やM&A(合併・買収)が、今後数年間の抗生物質市場の成長を促進する主要な理由の1つであると位置付けています。また、患者支援プログラム(PAPS)の存在や、抗生物質研究のための連邦政府や機関投資家の資金調達の増加は、市場の大きな需要につながるでしょう。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 市場情勢

  • 市場エコシステム

第3章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2022
  • 市場の見通し:2022-2027年の予測

第4章 市場規模実績

  • 2022年から2027年の世界の抗生物質市場
  • 製品セグメント分析2022-2027
  • 投与経路セグメント分析2022年~2027年
  • 地域セグメント分析2022-2027
  • 国セグメント分析2022-2027

第5章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第6章 製品別の市場セグメンテーション

  • 市場内訳
  • 製品別比較
  • 広域抗生物質 - 市場規模と予測 2022-2027
  • 狭スペクトル抗生物質 - 市場規模と予測 2022-2027
  • 製品別の市場機会

第7章 管理経路別市場セグメンテーション

  • 市場内訳
  • 投与経路別比較
  • 静脈内 - 市場規模と予測 2022-2027
  • 経口 - 市場規模と予測 2022-2027
  • その他 - 市場規模と予測 2022-2027
  • 投与経路別の市場機会

第8章 顧客情勢

  • 顧客情勢の概要

第9章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • アジア - 市場規模と予測 2022-2027
  • 北米 - 市場規模と予測 2022-2027
  • 欧州 - 市場規模と予測 2022-2027
  • その他の地域(ROW) - 市場規模と予測 2022-2027
  • 米国 - 市場規模と予測 2022-2027
  • 中国 - 市場規模と予測 2022-2027
  • インド - 市場規模と予測 2022-2027
  • 英国 - 市場規模と予測 2022-2027
  • 日本 - 市場規模と予測 2022-2027
  • 地域情勢別の市場機会

第10章 促進要因、課題、および動向

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場動向

第11章 ベンダー情勢

  • 概要
  • ベンダー情勢
  • 混乱の状況
  • 業界のリスク

第12章 ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Abbott Laboratories
  • AbbVie Inc.
  • Aspen Pharmacare Holdings Ltd
  • Astellas Pharma Inc.
  • Aurobindo Pharma Ltd.
  • Bayer AG
  • F. Hoffmann La Roche Ltd.
  • GlaxoSmithKline Plc
  • Incepta Pharmaceuticals Ltd.
  • Johnson and Johnson
  • Lupin Ltd.
  • Mayne Pharma Group Ltd.
  • Merck KGaA
  • Pfizer Inc.
  • Sanofi SA

第13章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Product
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits18: Historic Market Size - Data Table on Global antibiotics market 2017 - 2021 ($ million)
  • Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
  • Exhibits20: Historic Market Size - Route of administration Segment 2017 - 2021 ($ million)
  • Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
  • Exhibits23: Five forces analysis - Comparison between 2022 and 2027
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • Exhibits29: Chart on Market condition - Five forces 2022 and 2027
  • Exhibits30: Chart on Product - Market share 2022-2027 (%)
  • Exhibits31: Data Table on Product - Market share 2022-2027 (%)
  • Exhibits32: Chart on Comparison by Product
  • Exhibits33: Data Table on Comparison by Product
  • Exhibits34: Chart on Broad-spectrum antibiotics - Market size and forecast 2022-2027 ($ million)
  • Exhibits35: Data Table on Broad-spectrum antibiotics - Market size and forecast 2022-2027 ($ million)
  • Exhibits36: Chart on Broad-spectrum antibiotics - Year-over-year growth 2022-2027 (%)
  • Exhibits37: Data Table on Broad-spectrum antibiotics - Year-over-year growth 2022-2027 (%)
  • Exhibits38: Chart on Narrow-spectrum antibiotics - Market size and forecast 2022-2027 ($ million)
  • Exhibits39: Data Table on Narrow-spectrum antibiotics - Market size and forecast 2022-2027 ($ million)
  • Exhibits40: Chart on Narrow-spectrum antibiotics - Year-over-year growth 2022-2027 (%)
  • Exhibits41: Data Table on Narrow-spectrum antibiotics - Year-over-year growth 2022-2027 (%)
  • Exhibits42: Market opportunity by Product ($ million)
  • Exhibits43: Chart on Route of Administration - Market share 2022-2027 (%)
  • Exhibits44: Data Table on Route of Administration - Market share 2022-2027 (%)
  • Exhibits45: Chart on Comparison by Route of Administration
  • Exhibits46: Data Table on Comparison by Route of Administration
  • Exhibits47: Chart on Intravenous - Market size and forecast 2022-2027 ($ million)
  • Exhibits48: Data Table on Intravenous - Market size and forecast 2022-2027 ($ million)
  • Exhibits49: Chart on Intravenous - Year-over-year growth 2022-2027 (%)
  • Exhibits50: Data Table on Intravenous - Year-over-year growth 2022-2027 (%)
  • Exhibits51: Chart on Oral - Market size and forecast 2022-2027 ($ million)
  • Exhibits52: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
  • Exhibits53: Chart on Oral - Year-over-year growth 2022-2027 (%)
  • Exhibits54: Data Table on Oral - Year-over-year growth 2022-2027 (%)
  • Exhibits55: Chart on Others - Market size and forecast 2022-2027 ($ million)
  • Exhibits56: Data Table on Others - Market size and forecast 2022-2027 ($ million)
  • Exhibits57: Chart on Others - Year-over-year growth 2022-2027 (%)
  • Exhibits58: Data Table on Others - Year-over-year growth 2022-2027 (%)
  • Exhibits59: Market opportunity by Route of Administration ($ million)
  • Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits61: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits63: Chart on Geographic comparison
  • Exhibits64: Data Table on Geographic comparison
  • Exhibits65: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits66: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits67: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits68: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits69: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits70: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits71: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits72: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits73: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits74: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits75: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits81: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits82: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits83: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibits84: Data Table on US - Year-over-year growth 2022-2027 (%)
  • Exhibits85: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibits86: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibits87: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibits88: Data Table on China - Year-over-year growth 2022-2027 (%)
  • Exhibits89: Chart on India - Market size and forecast 2022-2027 ($ million)
  • Exhibits90: Data Table on India - Market size and forecast 2022-2027 ($ million)
  • Exhibits91: Chart on India - Year-over-year growth 2022-2027 (%)
  • Exhibits92: Data Table on India - Year-over-year growth 2022-2027 (%)
  • Exhibits93: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibits94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibits95: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits96: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibits98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibits99: Chart on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibits100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibits101: Market opportunity By Geographical Landscape ($ million)
  • Exhibits102: Impact of drivers and challenges in 2022 and 2027
  • Exhibits103: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits104: Overview on factors of disruption
  • Exhibits105: Impact of key risks on business
  • Exhibits106: Vendors covered
  • Exhibits107: Matrix on vendor position and classification
  • Exhibits108: Abbott Laboratories - Overview
  • Exhibits109: Abbott Laboratories - Business segments
  • Exhibits110: Abbott Laboratories - Key news
  • Exhibits111: Abbott Laboratories - Key offerings
  • Exhibits112: Abbott Laboratories - Segment focus
  • Exhibits113: AbbVie Inc. - Overview
  • Exhibits114: AbbVie Inc. - Product / Service
  • Exhibits115: AbbVie Inc. - Key news
  • Exhibits116: AbbVie Inc. - Key offerings
  • Exhibits117: Aspen Pharmacare Holdings Ltd - Overview
  • Exhibits118: Aspen Pharmacare Holdings Ltd - Business segments
  • Exhibits119: Aspen Pharmacare Holdings Ltd - Key offerings
  • Exhibits120: Aspen Pharmacare Holdings Ltd - Segment focus
  • Exhibits121: Astellas Pharma Inc. - Overview
  • Exhibits122: Astellas Pharma Inc. - Product / Service
  • Exhibits123: Astellas Pharma Inc. - Key offerings
  • Exhibits124: Aurobindo Pharma Ltd. - Overview
  • Exhibits125: Aurobindo Pharma Ltd. - Product / Service
  • Exhibits126: Aurobindo Pharma Ltd. - Key offerings
  • Exhibits127: Bayer AG - Overview
  • Exhibits128: Bayer AG - Business segments
  • Exhibits129: Bayer AG - Key offerings
  • Exhibits130: Bayer AG - Segment focus
  • Exhibits131: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits132: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits133: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits134: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits135: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits136: GlaxoSmithKline Plc - Overview
  • Exhibits137: GlaxoSmithKline Plc - Business segments
  • Exhibits138: GlaxoSmithKline Plc - Key offerings
  • Exhibits139: GlaxoSmithKline Plc - Segment focus
  • Exhibits140: Incepta Pharmaceuticals Ltd. - Overview
  • Exhibits141: Incepta Pharmaceuticals Ltd. - Product / Service
  • Exhibits142: Incepta Pharmaceuticals Ltd. - Key offerings
  • Exhibits143: Johnson and Johnson - Overview
  • Exhibits144: Johnson and Johnson - Business segments
  • Exhibits145: Johnson and Johnson - Key news
  • Exhibits146: Johnson and Johnson - Key offerings
  • Exhibits147: Johnson and Johnson - Segment focus
  • Exhibits148: Lupin Ltd. - Overview
  • Exhibits149: Lupin Ltd. - Product / Service
  • Exhibits150: Lupin Ltd. - Key news
  • Exhibits151: Lupin Ltd. - Key offerings
  • Exhibits152: Mayne Pharma Group Ltd. - Overview
  • Exhibits153: Mayne Pharma Group Ltd. - Business segments
  • Exhibits154: Mayne Pharma Group Ltd. - Key offerings
  • Exhibits155: Mayne Pharma Group Ltd. - Segment focus
  • Exhibits156: Merck KGaA - Overview
  • Exhibits157: Merck KGaA - Business segments
  • Exhibits158: Merck KGaA - Key news
  • Exhibits159: Merck KGaA - Key offerings
  • Exhibits160: Merck KGaA - Segment focus
  • Exhibits161: Pfizer Inc. - Overview
  • Exhibits162: Pfizer Inc. - Product / Service
  • Exhibits163: Pfizer Inc. - Key news
  • Exhibits164: Pfizer Inc. - Key offerings
  • Exhibits165: Sanofi SA - Overview
  • Exhibits166: Sanofi SA - Business segments
  • Exhibits167: Sanofi SA - Key news
  • Exhibits168: Sanofi SA - Key offerings
  • Exhibits169: Sanofi SA - Segment focus
  • Exhibits170: Inclusions checklist
  • Exhibits171: Exclusions checklist
  • Exhibits172: Currency conversion rates for US$
  • Exhibits173: Research methodology
  • Exhibits174: Validation techniques employed for market sizing
  • Exhibits175: Information sources
  • Exhibits176: List of abbreviations
目次
Product Code: IRTNTR41323

Technavio has been monitoring the antibiotics market and it is poised to grow by $17066.66 mn during 2022-2027, accelerating at a CAGR of 6.07% during the forecast period. Our report on the antibiotics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of infectious diseases, growing awareness of various diseases and their treatment, and special regulatory designations.

Technavio's antibiotics market is segmented as below:

By Route Of Administration

  • Intravenous
  • Oral
  • Others

By Product

  • Broad-spectrum antibiotics
  • Narrow-spectrum antibiotics

By Geographical Landscape

  • Asia
  • North America
  • Europe
  • Rest of World (ROW)

This study identifies strategic alliances and mergers and acquisitions (M&A) as one of the prime reasons driving the antibiotics market growth during the next few years. Also, the presence of patient assistance programs (PAPS) and increased federal and institutional funding for antibiotic research will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters. Our report on the antibiotics market covers the following areas:

  • Antibiotics market sizing
  • Antibiotics market forecast
  • Antibiotics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading antibiotics market vendors that include Abbott Laboratories, AbbVie Inc., Armata Pharmaceuticals Inc., Aspen Pharmacare Holdings Ltd, Astellas Pharma Inc., Aurobindo Pharma Ltd., Bayer AG, F. Hoffmann La Roche Ltd., Flynn Pharma Ltd., GlaxoSmithKline Plc, Incepta Pharmaceuticals Ltd., Johnson and Johnson, Lupin Ltd., Mayne Pharma Group Ltd., Melinta Therapeutics LLC, Merck KGaA, Pfizer Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and Teva Pharmaceutical Industries Ltd. Also, the antibiotics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Route of Administration
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027
  • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global antibiotics market 2022 - 2027
  • Exhibit 18: Historic Market Size - Data Table on Global antibiotics market 2022 - 2027 ($ million)
  • 4.2 Product Segment Analysis 2022 - 2027
  • Exhibit 19: Historic Market Size - Product Segment 2022 - 2027 ($ million)
  • 4.3 Route of administration Segment Analysis 2022 - 2027
  • Exhibit 20: Historic Market Size - Route of administration Segment 2022 - 2027 ($ million)
  • 4.4 Geography Segment Analysis 2022 - 2027
  • Exhibit 21: Historic Market Size - Geography Segment 2022 - 2027 ($ million)
  • 4.5 Country Segment Analysis 2022 - 2027
  • Exhibit 22: Historic Market Size - Country Segment 2022 - 2027 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product

  • 6.1 Market segments
  • Exhibit 30: Chart on Product - Market share 2022-2027 (%)
  • Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
  • 6.2 Comparison by Product
  • Exhibit 32: Chart on Comparison by Product
  • Exhibit 33: Data Table on Comparison by Product
  • 6.3 Broad-spectrum antibiotics - Market size and forecast 2022-2027
  • Exhibit 34: Chart on Broad-spectrum antibiotics - Market size and forecast 2022-2027 ($ million)
  • Exhibit 35: Data Table on Broad-spectrum antibiotics - Market size and forecast 2022-2027 ($ million)
  • Exhibit 36: Chart on Broad-spectrum antibiotics - Year-over-year growth 2022-2027 (%)
  • Exhibit 37: Data Table on Broad-spectrum antibiotics - Year-over-year growth 2022-2027 (%)
  • 6.4 Narrow-spectrum antibiotics - Market size and forecast 2022-2027
  • Exhibit 38: Chart on Narrow-spectrum antibiotics - Market size and forecast 2022-2027 ($ million)
  • Exhibit 39: Data Table on Narrow-spectrum antibiotics - Market size and forecast 2022-2027 ($ million)
  • Exhibit 40: Chart on Narrow-spectrum antibiotics - Year-over-year growth 2022-2027 (%)
  • Exhibit 41: Data Table on Narrow-spectrum antibiotics - Year-over-year growth 2022-2027 (%)
  • 6.5 Market opportunity by Product
  • Exhibit 42: Market opportunity by Product ($ million)

7 Market Segmentation by Route of Administration

  • 7.1 Market segments
  • Exhibit 43: Chart on Route of Administration - Market share 2022-2027 (%)
  • Exhibit 44: Data Table on Route of Administration - Market share 2022-2027 (%)
  • 7.2 Comparison by Route of Administration
  • Exhibit 45: Chart on Comparison by Route of Administration
  • Exhibit 46: Data Table on Comparison by Route of Administration
  • 7.3 Intravenous - Market size and forecast 2022-2027
  • Exhibit 47: Chart on Intravenous - Market size and forecast 2022-2027 ($ million)
  • Exhibit 48: Data Table on Intravenous - Market size and forecast 2022-2027 ($ million)
  • Exhibit 49: Chart on Intravenous - Year-over-year growth 2022-2027 (%)
  • Exhibit 50: Data Table on Intravenous - Year-over-year growth 2022-2027 (%)
  • 7.4 Oral - Market size and forecast 2022-2027
  • Exhibit 51: Chart on Oral - Market size and forecast 2022-2027 ($ million)
  • Exhibit 52: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
  • Exhibit 53: Chart on Oral - Year-over-year growth 2022-2027 (%)
  • Exhibit 54: Data Table on Oral - Year-over-year growth 2022-2027 (%)
  • 7.5 Others - Market size and forecast 2022-2027
  • Exhibit 55: Chart on Others - Market size and forecast 2022-2027 ($ million)
  • Exhibit 56: Data Table on Others - Market size and forecast 2022-2027 ($ million)
  • Exhibit 57: Chart on Others - Year-over-year growth 2022-2027 (%)
  • Exhibit 58: Data Table on Others - Year-over-year growth 2022-2027 (%)
  • 7.6 Market opportunity by Route of Administration
  • Exhibit 59: Market opportunity by Route of Administration ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 61: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibit 62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • 9.2 Geographic comparison
  • Exhibit 63: Chart on Geographic comparison
  • Exhibit 64: Data Table on Geographic comparison
  • 9.3 Asia - Market size and forecast 2022-2027
  • Exhibit 65: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 66: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 67: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibit 68: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • 9.4 North America - Market size and forecast 2022-2027
  • Exhibit 69: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 70: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 71: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibit 72: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • 9.5 Europe - Market size and forecast 2022-2027
  • Exhibit 73: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 74: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 75: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibit 76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
  • Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • 9.7 US - Market size and forecast 2022-2027
  • Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
  • 9.8 China - Market size and forecast 2022-2027
  • Exhibit 85: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 86: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 87: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibit 88: Data Table on China - Year-over-year growth 2022-2027 (%)
  • 9.9 India - Market size and forecast 2022-2027
  • Exhibit 89: Chart on India - Market size and forecast 2022-2027 ($ million)
  • Exhibit 90: Data Table on India - Market size and forecast 2022-2027 ($ million)
  • Exhibit 91: Chart on India - Year-over-year growth 2022-2027 (%)
  • Exhibit 92: Data Table on India - Year-over-year growth 2022-2027 (%)
  • 9.10 UK - Market size and forecast 2022-2027
  • Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • 9.11 Japan - Market size and forecast 2022-2027
  • Exhibit 97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibit 98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibit 99: Chart on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibit 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
  • 9.12 Market opportunity By Geographical Landscape
  • Exhibit 101: Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 102: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 104: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 105: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 106: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 107: Matrix on vendor position and classification
  • 12.3 Abbott Laboratories
  • Exhibit 108: Abbott Laboratories - Overview
  • Exhibit 109: Abbott Laboratories - Business segments
  • Exhibit 110: Abbott Laboratories - Key news
  • Exhibit 111: Abbott Laboratories - Key offerings
  • Exhibit 112: Abbott Laboratories - Segment focus
  • 12.4 AbbVie Inc.
  • Exhibit 113: AbbVie Inc. - Overview
  • Exhibit 114: AbbVie Inc. - Product / Service
  • Exhibit 115: AbbVie Inc. - Key news
  • Exhibit 116: AbbVie Inc. - Key offerings
  • 12.5 Aspen Pharmacare Holdings Ltd
  • Exhibit 117: Aspen Pharmacare Holdings Ltd - Overview
  • Exhibit 118: Aspen Pharmacare Holdings Ltd - Business segments
  • Exhibit 119: Aspen Pharmacare Holdings Ltd - Key offerings
  • Exhibit 120: Aspen Pharmacare Holdings Ltd - Segment focus
  • 12.6 Astellas Pharma Inc.
  • Exhibit 121: Astellas Pharma Inc. - Overview
  • Exhibit 122: Astellas Pharma Inc. - Product / Service
  • Exhibit 123: Astellas Pharma Inc. - Key offerings
  • 12.7 Aurobindo Pharma Ltd.
  • Exhibit 124: Aurobindo Pharma Ltd. - Overview
  • Exhibit 125: Aurobindo Pharma Ltd. - Product / Service
  • Exhibit 126: Aurobindo Pharma Ltd. - Key offerings
  • 12.8 Bayer AG
  • Exhibit 127: Bayer AG - Overview
  • Exhibit 128: Bayer AG - Business segments
  • Exhibit 129: Bayer AG - Key offerings
  • Exhibit 130: Bayer AG - Segment focus
  • 12.9 F. Hoffmann La Roche Ltd.
  • Exhibit 131: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 132: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 133: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 134: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 135: F. Hoffmann La Roche Ltd. - Segment focus
  • 12.10 GlaxoSmithKline Plc
  • Exhibit 136: GlaxoSmithKline Plc - Overview
  • Exhibit 137: GlaxoSmithKline Plc - Business segments
  • Exhibit 138: GlaxoSmithKline Plc - Key offerings
  • Exhibit 139: GlaxoSmithKline Plc - Segment focus
  • 12.11 Incepta Pharmaceuticals Ltd.
  • Exhibit 140: Incepta Pharmaceuticals Ltd. - Overview
  • Exhibit 141: Incepta Pharmaceuticals Ltd. - Product / Service
  • Exhibit 142: Incepta Pharmaceuticals Ltd. - Key offerings
  • 12.12 Johnson and Johnson
  • Exhibit 143: Johnson and Johnson - Overview
  • Exhibit 144: Johnson and Johnson - Business segments
  • Exhibit 145: Johnson and Johnson - Key news
  • Exhibit 146: Johnson and Johnson - Key offerings
  • Exhibit 147: Johnson and Johnson - Segment focus
  • 12.13 Lupin Ltd.
  • Exhibit 148: Lupin Ltd. - Overview
  • Exhibit 149: Lupin Ltd. - Product / Service
  • Exhibit 150: Lupin Ltd. - Key news
  • Exhibit 151: Lupin Ltd. - Key offerings
  • 12.14 Mayne Pharma Group Ltd.
  • Exhibit 152: Mayne Pharma Group Ltd. - Overview
  • Exhibit 153: Mayne Pharma Group Ltd. - Business segments
  • Exhibit 154: Mayne Pharma Group Ltd. - Key offerings
  • Exhibit 155: Mayne Pharma Group Ltd. - Segment focus
  • 12.15 Merck KGaA
  • Exhibit 156: Merck KGaA - Overview
  • Exhibit 157: Merck KGaA - Business segments
  • Exhibit 158: Merck KGaA - Key news
  • Exhibit 159: Merck KGaA - Key offerings
  • Exhibit 160: Merck KGaA - Segment focus
  • 12.16 Pfizer Inc.
  • Exhibit 161: Pfizer Inc. - Overview
  • Exhibit 162: Pfizer Inc. - Product / Service
  • Exhibit 163: Pfizer Inc. - Key news
  • Exhibit 164: Pfizer Inc. - Key offerings
  • 12.17 Sanofi SA
  • Exhibit 165: Sanofi SA - Overview
  • Exhibit 166: Sanofi SA - Business segments
  • Exhibit 167: Sanofi SA - Key news
  • Exhibit 168: Sanofi SA - Key offerings
  • Exhibit 169: Sanofi SA - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 170: Inclusions checklist
  • Exhibit 171: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 172: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 173: Research methodology
  • Exhibit 174: Validation techniques employed for market sizing
  • Exhibit 175: Information sources
  • 13.5 List of abbreviations
  • Exhibit 176: List of abbreviations